Diagonal Bio AB (publ) announced a significant new collaboration with Löberöds Hästklinik, led by renowned sporthorse veterinarian Lisa Lidbeck. The agreement, set to last an initial term of three months, will involve a pilot testing program focused on utilizing Diagonal Bio's platform technology, LAMPlify®, for the detection of respiratory viral infections in sporthorses. Lisa Lidbeck, an FEI (Fédération Equestre International-Internationella Ridsportförbundet) Veterinarian, and former Team Veterinarian for the Swedish National Eventing Team, brings a wealth of experience and an extensive international network to this collaboration.

Her expertise in managing health care for high-performance sporthorses is expected to be instrumental in advancing Diagonal Bio's platform technology, LAMPlify®, and veterinary diagnostic capabilities. The collaboration aims to leverage Lisa Lidbeck's deep understanding of equine health challenges, particularly in high-stakes competitive environments. The agreement is set for an initial three-month pilot study and represents a strategic opportunity to refine and expand the Company's diagnostic solutions within the veterinary field.

This initiative is aimed at enhancing health outcomes for sporthorses and ensuring more secure equestrian events globally. Only in Europe, there are a vast number of horse events yearly. In UK and France, there were more than 17 000 competitions in 2023.